Obermatt
See Similar Stocks →

Kestra Medical Technologies

NSQ:KMTS · BMG524411052
Health Care Equipment & SuppliesSmall

360

21
Profit price59
Owner Earnings Yield1
Dividend Yield1
Price/Sales25
EV / Gross Profit3
Price/Book18
Return on Capital5
Cash Return on Capital8
Return on Equity7
EBIT Margin4
Gross Profitability6
Accruals68
Owner Earnings Margin6
Sales growth82
Profit Growth20
Long-Term EPS Growth84
Reinvestment51
Price momentum28
Debt load60
Refinancing28
Debt Payback1
Liquidity21
Analyst ratings65
Opinion Changes11
Price Target Upside49
Market mood85
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Kestra Medical Technologies clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2021
Employees383
ISINBMG524411052
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Digital WellnessMHealthCardiovascularBiomedical EngineeringWearablesSensorsSmart ClothingHealth DiagnosticsHealth CareMedical Device

Description

Kestra Medical Technologies, Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. The company focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention te…

Analysis

Story stock

Kestra Medical Technologies, Ltd. trades at an expensive price on a weak set of business metrics, a combination we flag as a story stock.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 8/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
11
2026

All-time high

14

Mar 2026

All-time low

11

Jun 2026

Average rank

13

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
25
—
—
—
Price/Earnings
76
—
—
—
Price/Book
18
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
26
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Kestra Medical Technologies with its peers
Natera
NSQ:NTRA
39
CountryUSA
IndustryBiotechnology
SizeLarge
Full Stock Analysis →
LifeStance Health
NSQ:LFST
80
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
iRhythm Technologies
NSQ:IRTC
12
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
MannKind
NMQ:MNKD
24
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Lexicon Pharmaceuticals
NAQ:LXRX
28
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Myriad Genetics
NSQ:MYGN
12
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →